The present invention discloses novel substituted imidazole compounds which have H
3
receptor antagonist or dual histamine-H
1
and H
3
receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such imidazoles as well as methods of using them to treat allergy, nasal congestion, inflammatory and CNS-related diseases and others.
本发明揭示了一种新型取代
咪唑化合物,具有H3受体拮抗剂或双
重组织胺H1和H3受体拮抗剂活性,以及制备这种化合物的方法。在另一种实施方案中,本发明揭示了包含这些
咪唑环化合物的药物组成物,以及使用它们治疗过敏、鼻塞、炎症和中枢神经系统相关疾病等方法。